Delivery Order SPE2DB20D2014-SPE2DB25FC96Q
Award Date 9/10/25
Potential Completion Date 9/11/25
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,785.13 with firm fixed pricing and an ultimate completion date of September 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this...
- This federal contract award is a Delivery Order valued at $2,432.95 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tenofovir Disoproxil Fumarate 300 mg tablets, with an ultimate completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,375.23 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a non-competitive procurement under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a firm fixed-price delivery order valued at $3,620.08 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Emtricitabine-Tenofovir 200-300 mg tablets in quantities of 30. This non-competitive delivery order, which serves military and federal healthcare systems, represents a single transaction under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. The pharmaceutical products will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units, with a ceiling value of $2,235.38. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, representing a single-unit pharmaceutical procurement without set-aside designation. The award was made competitively to AmerisourceBergen Drug Corp, a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in units of 30s, with a ceiling value of $3,142.77 and a firm fixed price structure. This non-set-aside competitive award is categorized as a delivery order under a larger contract vehicle and represents a single transaction within AmerisourceBergen's extensive pharmaceutical distribution portfolio supporting federal...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,346.16 to AmerisourceBergen Drug Corp for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This non-set-aside, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Emtricitabine-Tenofovir (200-300mg) in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $3,198.40 and an ultimate completion date of August 22, 2025. The contract was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,777.32, is for the delivery of Tenofovir Disoproxil Fumarate 300 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The Defense Logistics Agency awarded a $20.4K firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tenkase 25 mg vials. This non-set-aside competitive award is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9M global pharmaceutical support vehicle active through December 2026. The place of performance is AmerisourceBergen's corporate office location...